P
Paolo Veronesi
Researcher at European Institute of Oncology
Publications - 344
Citations - 23643
Paolo Veronesi is an academic researcher from European Institute of Oncology. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 68, co-authored 299 publications receiving 21228 citations. Previous affiliations of Paolo Veronesi include European Institute & University of Milan.
Papers
More filters
Journal ArticleDOI
A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer.
Umberto Veronesi,Giovanni Paganelli,Giuseppe Viale,Alberto Luini,Stefano Zurrida,Viviana Galimberti,Mattia Intra,Paolo Veronesi,Chris Robertson,Patrick Maisonneuve,Giuseppe Renne,Concetta De Cicco,Francesca De Lucia,R. Gennari +13 more
TL;DR: Sentinel-node biopsy is a safe and accurate method of screening the axillary nodes for metastasis in women with a small breast cancer.
Journal ArticleDOI
Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
Umberto Veronesi,Giovanni Paganelli,Viviana Galimberti,Giuseppe Viale,Stefano Zurrida,Marilia Bedoni,Alberto Costa,Concetta De Cicco,James Geraghty,Alberto Luini,Virgilio Sacchini,Paolo Veronesi +11 more
TL;DR: Patients without clinical involvement of the axilla should undergo sentinel-node biopsy routinely, and may be spared complete axillary dissection when the sentinel node is disease-free, and thereby provide important information about the status of axillary nodes.
A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer
Umberto Veronesi,Giovanni Paganelli,Giuseppe Viale,Alberto Luini,S. Zurrida,Viviana Galimberti,Mattia Intra,Paolo Veronesi,Chris Robertson,Patrick Maisonneuve,Giuseppe Renne,C. De Cicco,F. De Lucia,R. Gennari +13 more
Journal ArticleDOI
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial
Viviana Galimberti,Bernard F. Cole,Bernard F. Cole,Stefano Zurrida,Giuseppe Viale,Giuseppe Viale,Alberto Luini,Paolo Veronesi,Paolo Veronesi,Paola Baratella,Camelia Chifu,Manuela Sargenti,Mattia Intra,Oreste Gentilini,Mauro G. Mastropasqua,Giovanni Mazzarol,Samuele Massarut,Jean Rémi Garbay,Janez Zgajnar,Hanne Galatius,Angelo Recalcati,David Littlejohn,Monika Bamert,Marco Colleoni,Karen N. Price,Meredith M. Regan,Aron Goldhirsch,Alan S. Coates,Richard D. Gelber,Umberto Veronesi +29 more
TL;DR: Axillary dissection could be avoided in patients with early breast cancer and limited sentinel-node involvement, thus eliminating complications of axillary surgery with no adverse effect on survival.
Journal ArticleDOI
Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series.
Umberto Veronesi,Giovanni Paganelli,Giuseppe Viale,Viviana Galimberti,Alberto Luini,Stefano Zurrida,Chris Robertson,Virgilio Sacchini,Paolo Veronesi,E. Orvieto,C. De Cicco,Mattia Intra,Giampiero Tosi,Daniela Scarpa +13 more
TL;DR: Sentinel lymph node biopsy using a gamma ray-detecting probe allows staging of the axilla with high accuracy in patients with primary breast cancer and is necessary to determine whether axillary dissection may be avoided in those patients with an uninvolved sentinel lymph nodes.